Viewing Study NCT02262520


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-21 @ 11:36 PM
Study NCT ID: NCT02262520
Status: COMPLETED
Last Update Posted: 2015-08-10
First Post: 2014-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CV185-028
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View